Stock Price Quote

PIRAMAL ENTERPRISES LTD.

NSE : PELBSE : 500302ISIN CODE : INE140A01024Industry : Pharmaceuticals & DrugsHouse : Piramal Ajay
BSE1599.4527.45 (+1.75 %)
PREV CLOSE ( ) 1572.00
OPEN PRICE ( ) 1571.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 107245
TODAY'S LOW / HIGH ( )1555.50 1633.00
52 WK LOW / HIGH ( )1271.07 2729.53
NSE1600.1027 (+1.72 %)
PREV CLOSE( ) 1573.10
OPEN PRICE ( ) 1573.10
BID PRICE (QTY) 1600.10 (54)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1829253
TODAY'S LOW / HIGH( ) 1553.75 1633.90
52 WK LOW / HIGH ( )1284.6 2721.19
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-04 1947
Management Info
Ajay G Piramal - Chairman - Managing Director
Registered Office

Address Piramal Ananta Agastya Corporate Park ,Opposite Fire Brigade , Kamani Junction , L B S Marg ,Kurla ( W ),
Mumbai,
Maharashtra-400070

Phone 022 3802 3000/4000

Email complianceofficer.phl@piramal.com

Website www.piramal.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

04Feb Piramal Enterprises reports 20% rise i
Piramal Enterprises has reported results for third quarter ended Decembe..
04Feb Piramal Enterprises zooms on reporting
Piramal Enterprises is currently trading at Rs. 1385.00, up by 47.10 poi..
28Jan Piramal Enterprises’ PPS planning to e
Piramal Enterprises’ Pharma Solutions business, a leading Contract Devel..
23Jan Cipla, Jindal Drilling and Piramal Ent
United States Food and Drug Administration (USFDA) has classified the in..
23Jan Piramal Enterprises’ rights issue over
Piramal Enterprises has successfully completed its Rights Issue that clo..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit367.200000000001-8619.8
Gross Profit 1127 -7915.8
Operating Profit 5307.421241.7
Net Sales 9156.736714

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7322.90 (2.05%)
M.Cap ( in Cr)16865.09
Ajanta Pharma (BSE)
peergroup  1446.05 (10.03%)
M.Cap ( in Cr)12618.42
Ipca Laboratories (BSE)
peergroup  1456.15 (3.43%)
M.Cap ( in Cr)18398.76
Solara Active Pharma (BSE)
peergroup  680.25 (6.01%)
M.Cap ( in Cr)1772.41
Alkem Laboratories (BSE)
peergroup  2657.75 (1.39%)
M.Cap ( in Cr)31777.39

Shareholding Pattern

FI/BANKS/INSURANCE 8.81%
PROMOTERS 46.06%
NON-INSTITUTION 14.99%
MUTUAL FUNDS/UTI 0.42%
GOVERNMENT 0%
FII 0%

About Piramal Enterprises Ltd.

Piramal Enterprises Ltd. was incorporated in the year 1947. Its today's share price is 1599.45. Its current market capitalisation stands at Rs 36073.72 Cr. In the latest quarter, company has reported Gross Sales of Rs. 132153.4 Cr and Total Income of Rs.135326.8 Cr. The company's management includes Vijay Shah, Arundhati Bhattacharya, N Vaghul, Deepak Satwalekar, S Ramadorai, Nandini Piramal, Anand Piramal, Goverdhan Mehta, R A Mashelkar, Keki Dadiseth, Gautam Banerjee, Swati A Piramal, Ajay G Piramal.

It is listed on the BSE with a BSE Code of 500302 , NSE with an NSE Symbol of PEL and ISIN of INE140A01024. It's Registered office is at Piramal Ananta Agastya Corporate Park ,Opposite Fire Brigade , Kamani Junction , L B S Marg ,Kurla ( W )Mumbai-400070, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Price Waterhouse

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X